Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Salesforce
CRM
|
+$208M |
| 2 |
Lowe's Companies
LOW
|
+$198M |
| 3 |
American Tower
AMT
|
+$161M |
| 4 |
Lennar Class A
LEN
|
+$150M |
| 5 |
British American Tobacco
BTI
|
+$150M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$208M |
| 2 |
CXO
CONCHO RESOURCES INC.
CXO
|
+$177M |
| 3 |
Crown Castle
CCI
|
+$168M |
| 4 |
Walmart Inc
WMT
|
+$167M |
| 5 |
Entergy
ETR
|
+$157M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 13.75% |
| 2 | Technology | 13.18% |
| 3 | Healthcare | 11.51% |
| 4 | Industrials | 10.45% |
| 5 | Consumer Discretionary | 9.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LCI
2826
DELISTED
Lannett Company, Inc.
LCI
| $515K | ﹤0.01% |
+6,977
| New | +$512K |
|
|
MSFG
2827
DELISTED
MainSource Financial Group Inc
MSFG
| $515K | ﹤0.01% |
14,356
-166,848
| -92% | -$5.66M |
|
2828
NatWest
NWG
$74.8B
| $514K | ﹤0.01% |
65,505
+55,114
| +530% | +$400K |
|
2829
CALL
Omnicell
OMCL
$1.53B
| $511K | ﹤0.01% |
+10,000
| New | +$479K |
|
2830
Willis Lease Finance
WLFC
$1.16B
| $510K | ﹤0.01% |
+62,184
| New | +$513K |
|
2831
Digi International
DGII
$2.85B
| $507K | ﹤0.01% |
+47,789
| New | +$460K |
|
2832
Coeur Mining
CDE
$21.9B
| $506K | ﹤0.01% |
+55,036
| New | +$468K |
|
2833
Resources Connection
RGP
$147M
| $505K | ﹤0.01% |
36,365
+8,421
| +30% | +$110K |
|
2834
Hurco Companies Inc
HURC
$147M
| $503K | ﹤0.01% |
12,089
+5,057
| +72% | +$179K |
|
|
PCO
2835
DELISTED
Pendrell Corporation - Class A
PCO
| $503K | ﹤0.01% |
737
-403
| -35% | -$273K |
|
2836
First Trust Exchange-Traded Fund IV First Trust Tactical High Yield ETF
HYLS
$1.64B
| $501K | ﹤0.01% |
+10,222
| New | +$504K |
|
2837
Wolverine World Wide
WWW
$1.69B
| $501K | ﹤0.01% |
17,350
-299,418
| -95% | -$8.13M |
|
2838
Ceragon Networks
CRNT
$188M
| $500K | ﹤0.01% |
240,204
+34,047
| +17% | +$76.8K |
|
|
SELF
2839
Global Self Storage
SELF
$64.3M
| $499K | ﹤0.01% |
+103,308
| New | +$503K |
|
2840
Ampco-Pittsburgh
AP
$182M
| $498K | ﹤0.01% |
+28,608
| New | +$431K |
|
2841
V2X
VVX
$2.4B
| $498K | ﹤0.01% |
+16,153
| New | +$501K |
|
|
RGLS
2842
DELISTED
Regulus Therapeutics
RGLS
| $497K | ﹤0.01% |
3,314
-605
| -15% | -$76.1K |
|
|
EVOL
2843
DELISTED
Evolving Systems, Inc.
EVOL
| $496K | ﹤0.01% |
102,252
+2,252
| +2% | +$10.9K |
|
|
GNC
2844
DELISTED
GNC Holdings, Inc.
GNC
| $495K | ﹤0.01% |
56,021
-44,873
| -44% | -$404K |
|
2845
Chubb
CB
$132B
| $494K | ﹤0.01% |
3,467
-20,131
| -85% | -$2.91M |
|
|
RNTX
2846
Rein Therapeutics
RNTX
$69.9M
| $494K | ﹤0.01% |
1,847
-4,257
| -70% | -$1.07M |
|
|
VBIV
2847
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
| $490K | ﹤0.01% |
+4,247
| New | +$510K |
|
|
IGD
2848
Voya Global Equity Dividend and Premium Opportunity Fund
IGD
$518M
| $488K | ﹤0.01% |
60,226
+15,523
| +35% | +$120K |
|
2849
Goldgroup Mining
GORO
$287M
| $487K | ﹤0.01% |
129,844
-120,918
| -48% | -$471K |
|
2850
HCA Healthcare
HCA
$92.7B
| $485K | ﹤0.01% |
6,092
-227,134
| -97% | -$18.3M |
|
Similar funds
Israel Englander's Q3 2017 Portfolio in Review
As of Q3 2017, Israel Englander held 4,198 positions worth $65.6B, up 17% from $56.1B the previous quarter. Its ten largest holdings account for 7.8% of the portfolio.
Israel Englander deployed $6.37B of net new capital in Q3 2017, opening 794 new positions and adding to 1,441 existing holdings. Its largest new stake was Northern Trust: 1,591,041 shares worth $146M.
By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 12% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Gilead Sciences, an estimated $208M trimmed.
- Israel Englander's largest Q3 2017 buy was Northern Trust: 1,591,041 shares worth $146M.
- Israel Englander added most to Salesforce in Q3 2017, an estimated $208M increase.
- Israel Englander's biggest Q3 2017 reduction was Gilead Sciences, cutting an estimated $208M.
- Israel Englander fully exited CONCHO RESOURCES INC. in Q3 2017, selling an estimated $177M.
- Israel Englander's ten largest holdings make up 7.8% of its $65.6B portfolio in Q3 2017.
- Israel Englander opened 794 new positions and closed 737 in Q3 2017.
- Israel Englander's portfolio value rose 17% quarter-over-quarter to $65.6B.
Based on Millennium Management's 13F filing for Q3 2017, filed 14 Nov 2017.